Cargando…

Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease

To better understand the development of dysphagia in patients with Parkinson disease (PD) and to identify possible neuromodulatory target regions of dysphagia, we studied the striatal dopamine transporter (DAT) availability distribution by subtype of dysphagia. METHODS: In this retrospective cross-s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji Hwan, Jeon, Jonghu, Lee, Young, Kim, Seung Min, Cheon, Miju, Kim, Jun Yup
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835674/ https://www.ncbi.nlm.nih.gov/pubmed/36607363 http://dx.doi.org/10.1097/RLU.0000000000004501

Ejemplares similares

Association of dysphagia with altered brain glucose metabolism in Parkinson's disease
por: Oh, Ji Yeon, et al.
Publicado: (2023)

Striatal Dopaminergic Functioning in Patients with Sporadic and Hereditary Spastic Paraplegias with Parkinsonism
por: Kim, Ji Seon, et al.
Publicado: (2013)

Molecular Imaging of Striatal Dopaminergic Neuronal Loss and the Neurovascular Unit in Parkinson Disease
por: Ivanidze, Jana, et al.
Publicado: (2020)

Distinct Role of Striatal Functional Connectivity and Dopaminergic Loss in Parkinson’s Symptoms
por: Dukart, Juergen, et al.
Publicado: (2017)

Dural Arteriovenous Fistula-Associated Reversible Parkinsonism with Presynaptic Dopaminergic Loss
por: Kim, Hang Rai, et al.
Publicado: (2015)

Dopaminergic medication reduces striatal sensitivity to negative outcomes in Parkinson’s disease
por: McCoy, Brónagh, et al.
Publicado: (2019)

Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease
por: Trinh, Ilene, et al.
Publicado: (2023)

Is Parkinson's Disease with History of Agent Orange Exposure Different from Idiopathic Parkinson's Disease?
por: Yang, YoungSoon, et al.
Publicado: (2016)

Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model
por: Morales, Ingrid, et al.
Publicado: (2017)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Rumex japonicus Houtt. Protects Dopaminergic Neurons by Regulating Mitochondrial Function and Gut–Brain Axis in In Vitro and In Vivo Models of Parkinson’s Disease
por: Kim, Hee-Young, et al.
Publicado: (2022)

PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson’s Disease
por: Choi, Yeon Joo, et al.
Publicado: (2021)

Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

Sequential Loss of LC Noradrenergic and Dopaminergic Neurons Results in a Correlation of Dopaminergic Neuronal Number to Striatal Dopamine Concentration
por: Szot, Patricia, et al.
Publicado: (2012)

Diagnostic Performance for Differential Diagnosis of Atypical Parkinsonian Syndromes from Parkinson’s Disease Using Quantitative Indices of (18)F-FP-CIT PET/CT
por: Cheon, Miju, et al.
Publicado: (2022)

Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2019)

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
por: Lee, Seung Ha, et al.
Publicado: (2017)

Alteration of Striatal Tetrahydrobiopterin in Iron-Induced Unilateral Model of Parkinson's Disease
por: Aryal, Bijay, et al.
Publicado: (2014)

18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease
por: Yang, YoungSoon, et al.
Publicado: (2017)

Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
por: Lee, Myung Jun, et al.
Publicado: (2021)

Seropositive Rheumatoid Arthritis Presenting with Reversible Parkinsonism and Dysphagia
por: Im, Seojun, et al.
Publicado: (2020)

NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-α-synuclein mouse model of Parkinson’s disease
por: Song, Min Kyung, et al.
Publicado: (2022)

Dysphagia for medication in Parkinson’s disease
por: Labeit, Bendix, et al.
Publicado: (2022)

Cicadidae Periostracum, the Cast-Off Skin of Cicada, Protects Dopaminergic Neurons in a Model of Parkinson's Disease
por: Lim, Hye-Sun, et al.
Publicado: (2019)

Striatal Neuroinflammation Promotes Parkinsonism in Rats
por: Choi, Dong-Young, et al.
Publicado: (2009)

Striatal dopaminergic lesions contributed to the disease severity in progressive supranuclear palsy
por: Chen, Ming-Jia, et al.
Publicado: (2022)

The neurogenetics of exploration and exploitation: Prefrontal and striatal dopaminergic components
por: Frank, Michael J., et al.
Publicado: (2009)

The Effects of the VFSS Timing After Nasogastric Tube Removal on Swallowing Function of the Patients With Dysphagia
por: Nam, Du Hyeon, et al.
Publicado: (2015)

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
por: Chung, Young Cheul, et al.
Publicado: (2013)

Clinical Practice Guidelines for Oropharyngeal Dysphagia
por: Yang, Seoyon, et al.
Publicado: (2023)

Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
por: Wang, Ronglin, et al.
Publicado: (2018)

Fluorodopa is a Promising Fluorine‐19 MRI Probe for Evaluating Striatal Dopaminergic Function in a Rat Model of Parkinson's Disease
por: Yanagisawa, Daijiro, et al.
Publicado: (2016)

Shared functional neural substrates in Parkinson's disease and drug-induced parkinsonism: association with dopaminergic depletion
por: Oh, Se Won, et al.
Publicado: (2020)

Author Correction: Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
por: Lee, Myung Jun, et al.
Publicado: (2022)

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
por: Song, Juhyun, et al.
Publicado: (2016)

Korean Red Ginseng protects dopaminergic neurons by suppressing the cleavage of p35 to p25 in a Parkinson's disease mouse model
por: Jun, Ye Lee, et al.
Publicado: (2015)

Selective Susceptibility of Human Dopaminergic Neural Stem Cells to Dopamine-Induced Apoptosis
por: Jeon, Sung-Man, et al.
Publicado: (2010)

Striatal Spine Plasticity in Parkinson's Disease
por: Villalba, Rosa M., et al.
Publicado: (2010)

Striatal synaptic adaptations in Parkinson’s disease
por: Shen, Weixing, et al.
Publicado: (2022)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5a0o4s0bj9e4fv8qr1f6710199